IDiyas

For the Inventor, By the Inventor

Demarest, NJ, United States of America

William J McGahren

USPTO Granted Patents = 12

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 853(Granted Patents)


Location History:

  • Dumont, NJ (US) (1980)
  • Demarest, NJ (US) (1976 - 1998)

Company Filing History:

goldMedal12 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1976-1998

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5770710 - Antitumor and antibacterial substituted disulfide derivatives prepared (1998-06-23),
2. 5770701 - Process for preparing targeted forms of methyltrithio antitumor agents (1998-06-23),
3. 5606040 - Antitumor and antibacterial substituted disulfide derivatives prepared (1997-02-25),
4. 5053394 - Targeted forms of methyltrithio antitumor agents (1991-10-01),
5. 4996305 - Process for producing the antibiotic and antitumor agents LL-E33288.epsilon (1991-02-26),
6. 4978748 - Intermediate and process for producing the antibacterial and antitumor (1990-12-18),
7. 4977143 - Antibacterial and antitumor agents LL-E33288EPSILON-I and (1990-12-11),
8. 4234717 - Antibacterial antibiotic BM782 (1980-11-18),
9. 4179451 - Novel hydroxy substituted 15-deoxy-5-cis-prostenoic acids and esters (1979-12-18),
10. 4107441 - Novel 16 hydroxy 15-deoxy-5-cis-prostenoic acids and esters (1978-08-15),
11. 4061672 - Derivatives of 9-hydroxy-13-trans-prostenoic acid (1977-12-06),
12. 3950406 - Hydroxylated 15-deoxy derivatives of 9-hydroxy-13-trans-prostenoic acid (1976-04-13),

Title: The Innovative Path of William J McGahren: A Pioneer in Antitumor and Antibacterial Technologies

Introduction:

William J McGahren, a prominent inventor based in Demarest, NJ, has made significant contributions to the field of pharmaceuticals and drug development. With an impressive portfolio of 12 patents, McGahren stands as a trailblazer in creating advanced antitumor and antibacterial solutions.

Latest Patents:

McGahren's latest patents showcase his expertise in developing cutting-edge pharmaceuticals. One of his recent inventions involves the production of substituted disulfide analogs, targeting antibacterial and antitumor properties within the LL-E33288 complex. Additionally, he has devised a method for constructing targeted forms of methyltrithio antitumor agents, demonstrating his innovative approach to drug conjugates.

Career Highlights:

Currently associated with the American Cyanamid Company, McGahren has leveraged his expertise to drive groundbreaking research and development initiatives. His strategic vision and commitment to advancing pharmaceutical technologies have established him as a key figure in the industry.

Collaborations:

Throughout his career, McGahren has collaborated with accomplished professionals such as George A Ellestad and Martin L Sassiver. By working alongside esteemed peers, he has been able to cultivate a rich network of knowledge exchange and synergistic innovation.

Conclusion:

In conclusion, William J McGahren's relentless pursuit of excellence in pharmaceutical innovation has positioned him as a pioneer in the field of antitumor and antibacterial technologies. His remarkable contributions continue to shape the landscape of drug development, inspiring future generations of inventors to push the boundaries of scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…